Identification and Functional Characterization of the Caenorhabditis elegans Riboflavin Transporters rft-1 and rft-2

Two potential orthologs of the human riboflavin transporter 3 (hRFVT3) were identified in the C. elegans genome, Y47D7A.16 and Y47D7A.14, which share 33.7 and 30.5% identity, respectively, with hRFVT3. The genes are tandemly arranged, and we assign them the names rft-1 (for Y47D7A.16) and rft-2 (for Y47D7A.14). Functional characterization of the coding sequences in a heterologous expression system demonstrated that both were specific riboflavin transporters, although the rft-1 encoded protein had greater transport activity. A more detailed examination of rft-1 showed its transport of riboflavin to have an acidic pH dependence, saturability (apparent Km = 1.4±0.5 µM), inhibition by riboflavin analogues, and Na+ independence. The expression of rft-1 mRNA was relatively higher in young larvae than in adults, and mRNA expression dropped in response to RF supplementation. Knocking down the two transporters individually via RNA interference resulted in a severe loss of fertility that was compounded in a double knockdown. Transcriptional fusions constructed with two fluorophores (rft-1::GFP, and rft-2::mCherry) indicated that rft-1 is expressed in the intestine and a small subset of neuronal support cells along the entire length of the animal. Expression of rft-2 is localized mainly to the intestine and pharynx. We also observed a drop in the expression of the two reporters in animals that were maintained in high riboflavin levels. These results report for the first time the identification of two riboflavin transporters in C. elegans and demonstrate their expression and importance to metabolic function in worms. Absence of transporter function renders worms sterile, making them useful in understanding human disease associated with mutations in hRFVT3.

[1]  W. G. Stevenson Riboflavin Deficiency. , 2022, Canadian journal of comparative medicine and veterinary science.

[2]  H. Said,et al.  Mechanism and regulation of vitamin B2 (riboflavin) uptake by mouse and human pancreatic β-cells/islets: physiological and molecular aspects. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[3]  H. Said,et al.  Effect of clinical mutations on functionality of the human riboflavin transporter-2 (hRFT-2). , 2012, Molecular genetics and metabolism.

[4]  C. Spagnoli,et al.  Brown‐Vialetto‐Van Laere syndrome and Fazio‐Londe disease – treatable motor neuron diseases of childhood , 2012, Developmental medicine and child neurology.

[5]  J. Marchant,et al.  Differential expression of human riboflavin transporters -1, -2, and -3 in polarized epithelia: a key role for hRFT-2 in intestinal riboflavin uptake. , 2011, Biochimica et biophysica acta.

[6]  Katsuhisa Inoue,et al.  Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption. , 2010, The Journal of nutrition.

[7]  K. Balamurugan,et al.  Knockout of the folate transporter folt-1 causes germline and somatic defects in C. elegans , 2010, BMC Developmental Biology.

[8]  Y. Crow,et al.  Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. , 2010, American journal of human genetics.

[9]  Yutong He,et al.  Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China. , 2009, Asian Pacific journal of cancer prevention : APJCP.

[10]  S. Sathasivam Brown-Vialetto-Van Laere syndrome , 2008, Orphanet journal of rare diseases.

[11]  M. Moussaif,et al.  the nematode, Caenorhabditis elegans , 2022 .

[12]  J. McGhee The C. elegans intestine. , 2007, WormBook : the online review of C. elegans biology.

[13]  Cori Bargmann Chemosensation in C. elegans. , 2006, WormBook : the online review of C. elegans biology.

[14]  T. Blumenthal Trans-splicing and operons. , 2005, WormBook : the online review of C. elegans biology.

[15]  V. Ganapathy,et al.  Relevance of NAC-2, an Na+-coupled citrate transporter, to life span, body size and fat content in Caenorhabditis elegans. , 2004, The Biochemical journal.

[16]  B. Lemire,et al.  Mitochondrial complex I mutations in Caenorhabditis elegans produce cytochrome c oxidase deficiency, oxidative stress and vitamin-responsive lactic acidosis. , 2003, Human molecular genetics.

[17]  V. Ganapathy,et al.  Structural and Functional Characteristics of Two Sodium-coupled Dicarboxylate Transporters (ceNaDC1 and ceNaDC2) fromCaenorhabditis elegans and Their Relevance to Life Span* , 2003, The Journal of Biological Chemistry.

[18]  Oliver Hobert,et al.  PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. , 2002, BioTechniques.

[19]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[20]  E. Park,et al.  Microbial production of riboflavin using riboflavin overproducers,Ashbya gossypii, Bacillus subtilis, andCandida famate: An overview , 2001 .

[21]  A. Fire,et al.  Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. , 2001, Gene.

[22]  V. Ganapathy,et al.  Identity of the F52F12.1 gene product in Caenorhabditis elegans as an organic cation transporter. , 1999, Biochimica et biophysica acta.

[23]  Kamble Sm,et al.  MOLYBDENUM, XANTHINE OXIDASE AND RIBOFLAVIN LEVELS IN TAMOXIFEN TREATED POSTMENOPAUSAL WOMEN WITH BREAST CANCER , 1998 .

[24]  L. Hjelmeland,et al.  ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. , 1996, Experimental eye research.

[25]  M Macaluso,et al.  A case control study of nutritional factors and cervical dysplasia. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  K. Krishnaswamy,et al.  Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  N. Munakata [Genetics of Caenorhabditis elegans]. , 1989, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[28]  C. Kenyon,et al.  The nematode Caenorhabditis elegans. , 1988, Science.

[29]  J. Vanfleteren,et al.  Intermediary metabolism. , 2009, WormBook : the online review of C. elegans biology.

[30]  M. Labouesse [Caenorhabditis elegans]. , 2003, Medecine sciences : M/S.

[31]  S. Kamble,et al.  Molybdenum, xanthine oxidase and riboflavin levels in tamoxifen treated postmenopausal women with breast cancer. , 1998, Indian journal of medical sciences.

[32]  W. Wood The Nematode Caenorhabditis elegans , 1988 .

[33]  L. Machlin Handbook of vitamins: nutritional, biochemical, and clinical aspects. , 1984 .